Mitigating Study Power Loss Caused by Clinical Trial Disruptions Due to the COVID-19 Pandemic: Leveraging External Data via Propensity Score-Integrated Approaches

The spread of COVID-19 has created tremendous challenges to ongoing clinical studies essential to finding effective treatments and cures for a myriad of diseases, with some studies having suspended...